Lung Cancer Screening: New Perspective and Challenges in Europe

Cancers

Annemiek Snoeckx¹  Jan P. Van Meerbeeck²  Paul Van Schil³  Brian Ward⁴  Emma O’Dowd⁵ 

[1]Department of Radiology, Antwerp University and Antwerp University Hospital, 2650 Edegem, Belgium

[2]Department of Thoracic Oncology, Antwerp University and Antwerp University Hospital, 2650 Edegem, Belgium

[3]Department of Thoracic and Vascular Surgery, Antwerp University and Antwerp University Hospital, 2650 Edegem, Belgium

[4]European Respiratory Society, Advocacy Department, 1000 Brussels, Belgium

[5]Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK

关键词: lung cancer;    screening;    computed tomography;    management;   

DOI  :  10.3390/cancers14092343

来源: DOAJ

【 摘 要 】

Randomized-controlled trials have shown clear evidence that lung cancer screening with low-dose CT in a high-risk population of current or former smokers can significantly reduce lung-cancer-specific mortality by an inversion of stage distribution at diagnosis. This paper will review areas in which there is good or emerging evidence and areas which still require investment, research or represent implementation challenges. The implementation of population-based lung cancer screening in Europe is variable and fragmented. A number of European countries seem be on the verge of implementing lung cancer screening, mainly through the implementation of studies or trials. The cost and capacity of CT scanners and radiologists are considered to be the main hurdles for future implementation. Actions by the European Commission, related to its published Europe’s Beating Cancer Plan and the proposal to update recommendations on cancer screening, could be an incentive to help speed up its implementation.

【 授权许可】

Unknown